Aehr Test Systems $AEHR Shares Purchased by HighTower Advisors LLC

HighTower Advisors LLC increased its holdings in shares of Aehr Test Systems (NASDAQ:AEHR) by 485.1% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 78,340 shares of the semiconductor company’s stock after buying an additional 64,950 shares during the period. HighTower Advisors LLC owned about 0.26% of Aehr Test Systems worth $2,359,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Jones Financial Companies Lllp grew its stake in shares of Aehr Test Systems by 3,448.3% in the third quarter. Jones Financial Companies Lllp now owns 1,029 shares of the semiconductor company’s stock worth $31,000 after acquiring an additional 1,000 shares in the last quarter. State of Wyoming purchased a new position in Aehr Test Systems in the second quarter valued at $28,000. CWM LLC grew its stake in Aehr Test Systems by 15.1% during the 2nd quarter. CWM LLC now owns 6,062 shares of the semiconductor company’s stock worth $78,000 after purchasing an additional 793 shares in the last quarter. Legal & General Group Plc grew its stake in Aehr Test Systems by 110.8% during the 2nd quarter. Legal & General Group Plc now owns 6,882 shares of the semiconductor company’s stock worth $89,000 after purchasing an additional 3,617 shares in the last quarter. Finally, SG Americas Securities LLC purchased a new stake in Aehr Test Systems during the 3rd quarter worth about $214,000. Hedge funds and other institutional investors own 69.69% of the company’s stock.

Insider Activity at Aehr Test Systems

In other Aehr Test Systems news, Director Rhea J. Posedel sold 13,998 shares of the business’s stock in a transaction that occurred on Friday, February 13th. The stock was sold at an average price of $30.02, for a total value of $420,219.96. Following the completion of the sale, the director owned 456,979 shares in the company, valued at approximately $13,718,509.58. The trade was a 2.97% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Laura Oliphant sold 4,546 shares of the firm’s stock in a transaction that occurred on Thursday, January 22nd. The stock was sold at an average price of $31.40, for a total transaction of $142,744.40. Following the transaction, the director owned 18,432 shares in the company, valued at approximately $578,764.80. This trade represents a 19.78% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders own 6.80% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms recently weighed in on AEHR. Lake Street Capital started coverage on shares of Aehr Test Systems in a research note on Wednesday, December 17th. They set a “buy” rating on the stock. Craig Hallum reissued a “hold” rating on shares of Aehr Test Systems in a research report on Friday, January 9th. Zacks Research raised shares of Aehr Test Systems from a “strong sell” rating to a “hold” rating in a research report on Monday, December 8th. Finally, Weiss Ratings reiterated a “sell (d)” rating on shares of Aehr Test Systems in a research note on Wednesday, January 21st. One equities research analyst has rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $21.00.

Aehr Test Systems Price Performance

Shares of NASDAQ:AEHR opened at $37.43 on Friday. Aehr Test Systems has a 12 month low of $6.27 and a 12 month high of $43.13. The firm has a market capitalization of $1.15 billion, a P/E ratio of -124.76 and a beta of 2.31. The company’s fifty day moving average price is $27.30 and its 200 day moving average price is $25.72.

Aehr Test Systems (NASDAQ:AEHR) last released its quarterly earnings data on Thursday, January 8th. The semiconductor company reported ($0.04) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.08) by $0.04. Aehr Test Systems had a negative net margin of 16.63% and a negative return on equity of 4.57%. The company had revenue of $9.88 million during the quarter, compared to the consensus estimate of $11.45 million. On average, sell-side analysts anticipate that Aehr Test Systems will post 0.1 EPS for the current year.

Aehr Test Systems Company Profile

Aehr Test Systems develops, manufactures and sells semiconductor test and burn-in equipment used by device manufacturers to ensure quality and reliability of integrated circuits. Its products are designed for wafer-level reliability assessment, functional test and stress screening of memory devices, system-on-chips, optical components and power semiconductors. By focusing on wafer-level burn-in and testing processes, the company helps reduce cost and improve yield for high-volume semiconductor production.

The company’s product portfolio includes FOX series wafer probe test and burn-in systems as well as ABTS burn-in ovens.